Failure of complete recanalization is associated with poor outcome after cardioembolic stroke

H S Nam1, K-Y Lee, Y D Kim

  • 1Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.

Insights

Complete recanalization after thrombolytic therapy is crucial for cardioembolic stroke outcomes. Failure to achieve full recanalization in these patients is common and predicts a poor prognosis.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Medicine

Background:

  • Recanalization significantly impacts outcomes following thrombolytic treatment.
  • Cardiac emboli, though fibrin-rich and responsive to fibrinolysis, are linked to poor stroke outcomes and high mortality.
  • The completeness of recanalization may critically influence the prognosis of cardioembolic stroke.

Purpose of the Study:

  • To determine if the degree of recanalization affects outcomes in patients with cardioembolic stroke treated with fibrinolysis.
  • To compare recanalization rates and outcomes between patients with and without cardiac sources of embolism (CSE).

Main Methods:

  • Enrolled consecutive stroke patients with arterial occlusions on CT angiography who received thrombolytic therapy.
  • Assessed recanalization completeness using the Thrombolysis in Myocardial Infarction (TIMI) grade.
  • Investigated independent predictors of poor outcome (modified Rankin Scale score 3-6) at 3 months.

Main Results:

  • Of 127 patients, 65 (51%) had CSE. Overall recanalization rates (TIMI 2 or 3) were similar between groups (65% vs. 68%, P=0.710).
  • Patients with CSE were significantly less likely to achieve complete recanalization (TIMI 3) compared to those without (19% vs. 39%, P=0.011).
  • CSE was associated with failure of complete recanalization (OR 2.809) and independently predicted poor 3-month outcome (OR 3.629).

Conclusions:

  • Failure to achieve complete recanalization is frequent in cardioembolic strokes treated with thrombolysis.
  • Incomplete recanalization is associated with poor outcomes after thrombolytic therapy for cardioembolic stroke.
Abstract